Most significantly, China’s influence has recently shifted from passive supply to active manipulation of the technological ...

Key Points GAAP revenue of $20.5 million in Q2 2025 surpassed analyst expectations by 9.3%, despite a decline from the same period in 2024. Non-GAAP loss per share was $(0.01) in Q2 2025. Cash ...

Considering moving abroad for research purposes? Three researchers share their experiences and explain why they ended up ...

Reiterating timelines for FDA submission in 2025Transplant clinical trial has attracted leading transplant hospitalsBooked ...

Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets.

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

Enables EverQuote to efficiently execute a portion of its $50 million Share Repurchase Program; Mr. Blundin remains EverQuote’s Chairman and largest shareholder; CAMBRIDGE, Mass ...

The following technology services are made available to you by the Humphrey School in partnership with the University of ...

Remote monitoring via microfluidic platforms, AI-assisted sensor systems, and more: Attendees of the Labmed Forum at Medica ...

Our review of the La Sportiva Prodigo Max, a companion to our top trail shoe of the year. Between ankle rolls, instability, ...

On 12 August 2025, ahead of its flagship summit in Bengaluru, the Economic Times will host a special livestream exploring ...